Trial Profile
Treatment-Resistant Depression Augmentation Therapy With An Analog of the Neuroactive Steroid Allopregnanolone: A Pilot Study
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 17 Sep 2021
Price :
$35
*
At a glance
- Drugs Ganaxolone (Primary)
- Indications Major depressive disorder
- Focus Therapeutic Use
- 09 Jun 2020 Results published in the Journal of Clinical Psychiatry
- 12 Sep 2018 Status changed from recruiting to completed.
- 12 Sep 2018 Status changed from recruiting to completed.